PMID: 16629383Apr 25, 2006Paper

RNA interference: a potential therapeutic tool for silencing splice isoforms linked to human diseases

BioTechniques
Rajesh K Gaur

Abstract

Alternative splicing of precursor messenger RNAs (pre-mRNAs) is one of the most important sources of protein diversity in vertebrates. An estimated 35%-70% of human genes generate transcripts that are alternatively spliced, and defects in this process are linked to numerous human genetic diseases and various forms of cancer. The discovery that 21-23 nucleotide RNA duplexes, known as small interfering RNAs (siRNAs), can knockdown the homologous mRNAs in mammalian cells has revolutionized many aspects of drug discovery including down-regulation of disease-associated splicing isoforms. In addition, RNA interference (RNAi)-mediated silencing of splicing regulators has the potential to define the complex network of alternative splicing regulation and to analyze gene function. In this review, I first provide a brief introduction to mRNA splicing and its relationship to human diseases. This is followed by a brief overview of RNAi. Finally I discuss the therapeutic potential of RNAi in targeting disease-linked splicing isoforms.

References

Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·M F ClarkeG Núñez
Dec 30, 1994·Biochimica Et Biophysica Acta·N E Hynes, D F Stern
Mar 1, 1996·British Journal of Haematology·L XerriD Birnbaum
Nov 10, 1998·Molecular Carcinogenesis·K Y Kwong, M C Hung
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·C L LorsonB Wirth
Jul 8, 1999·Current Opinion in Cell Biology·A M Krecic, M S Swanson
Apr 15, 2000·Cellular and Molecular Life Sciences : CMLS·A V Philips, T A Cooper
Jul 26, 2000·The Journal of Cell Biology·S M Mount, H K Salz
Aug 31, 2000·Japanese Journal of Cancer Research : Gann·M E NitaH Nagawa
Feb 7, 2001·Genes & Development·S M ElbashirT Tuschl
Mar 20, 2001·Nature Reviews. Neuroscience·B K DredgeR B Darnell
Aug 25, 2001·Annual Review of Neuroscience·V M LeeJ Q Trojanowski
Aug 28, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U NovakM F Fey
Feb 23, 2002·Trends in Genetics : TIG·Malka Nissim-Rafinia, Batsheva Kerem
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
Apr 18, 2002·Genes & Development·Patrick J PaddisonDouglas S Conklin
Apr 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jenn-Yah YuDavid L Turner
May 1, 2002·Nature Biotechnology·Cynthia P PaulDavid R Engelke
May 8, 2002·Nature Reviews. Molecular Cell Biology·Gideon DreyfussNaoyuki Kataoka

❮ Previous
Next ❯

Citations

Nov 13, 2008·Molecular Cancer Therapeutics·Farnaz YamoutpourFaris Farassati
Mar 31, 2009·BMC Molecular Biology·Aaron M GruverDouglas L Pittman
Feb 13, 2008·BMC Molecular Biology·Dong-Suk KimRajesh K Gaur
Jul 3, 2007·PLoS Genetics·Matthew WoodGraham McClorey
Jan 5, 2010·IEEE Signal Processing Magazine·Yufei HuangYufeng Wang
Dec 17, 2016·Cancer Biomarkers : Section a of Disease Markers·Jian-Qiang LiXin-Ming Zhou
Mar 9, 2011·Genomics, Proteomics & Bioinformatics·Yunfeng FengGregory D Longmore

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.